Published in Antimicrob Agents Chemother on December 01, 2004
A phenotypic profile of the Candida albicans regulatory network. PLoS Genet (2009) 2.86
A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics (2006) 2.54
Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates. Eukaryot Cell (2007) 2.25
Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol Mol Biol Rev (2011) 1.90
Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains. Mol Microbiol (2008) 1.90
Control of the C. albicans cell wall damage response by transcriptional regulator Cas5. PLoS Pathog (2006) 1.57
Antifungal resistance and new strategies to control fungal infections. Int J Microbiol (2011) 1.44
Efflux in fungi: la pièce de résistance. PLoS Pathog (2009) 1.33
Multidrug resistance in fungi. Eukaryot Cell (2007) 1.20
Role of Ndt80p in sterol metabolism regulation and azole resistance in Candida albicans. Eukaryot Cell (2009) 1.17
VIB-1 is required for expression of genes necessary for programmed cell death in Neurospora crassa. Eukaryot Cell (2006) 1.17
Genetic control of conventional and pheromone-stimulated biofilm formation in Candida albicans. PLoS Pathog (2013) 1.09
Role of transcription factor CaNdt80p in cell separation, hyphal growth, and virulence in Candida albicans. Eukaryot Cell (2010) 0.97
Transcriptional activation and increased mRNA stability contribute to overexpression of CDR1 in azole-resistant Candida albicans. Antimicrob Agents Chemother (2008) 0.94
Fluconazole transport into Candida albicans secretory vesicles by the membrane proteins Cdr1p, Cdr2p, and Mdr1p. Eukaryot Cell (2010) 0.92
The transcription factor Ndt80 does not contribute to Mrr1-, Tac1-, and Upc2-mediated fluconazole resistance in Candida albicans. PLoS One (2011) 0.91
Identification and functional characterization of Rca1, a transcription factor involved in both antifungal susceptibility and host response in Candida albicans. Eukaryot Cell (2012) 0.91
Meiotic regulators Ndt80 and ime2 have different roles in Saccharomyces and Neurospora. Genetics (2010) 0.86
Novel Regulatory Mechanisms of Pathogenicity and Virulence to Combat MDR in Candida albicans. Int J Microbiol (2013) 0.86
Serum repressing efflux pump CDR1 in Candida albicans. BMC Mol Biol (2006) 0.82
Ncb2 is involved in activated transcription of CDR1 in azole-resistant clinical isolates of Candida albicans. Eukaryot Cell (2011) 0.82
The role of Candida albicans homologous recombination factors Rad54 and Rdh54 in DNA damage sensitivity. BMC Microbiol (2011) 0.78
VibA, a homologue of a transcription factor for fungal heterokaryon incompatibility, is involved in antifungal compound production in the plant-symbiotic fungus Epichloë festucae. Eukaryot Cell (2014) 0.78
The ABCs of Candida albicans Multidrug Transporter Cdr1. Eukaryot Cell (2015) 0.76
The global regulator Ncb2 escapes from the core promoter and impacts transcription in response to drug stress in Candida albicans. Sci Rep (2017) 0.75
Extreme Diversity in the Regulation of Ndt80-Like Transcription Factors in Fungi. G3 (Bethesda) (2015) 0.75
A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics (1989) 105.30
The transcriptional program of sporulation in budding yeast. Science (1998) 37.23
Multifunctional yeast high-copy-number shuttle vectors. Gene (1992) 19.47
Nonfilamentous C. albicans mutants are avirulent. Cell (1997) 13.83
Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet (1984) 11.51
Rapid hypothesis testing with Candida albicans through gene disruption with short homology regions. J Bacteriol (1999) 10.31
Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science (1994) 8.59
Yeast shuttle and integrative vectors with multiple cloning sites suitable for construction of lacZ fusions. Gene (1986) 7.67
A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport. Trends Biochem Sci (1993) 7.14
Getting started with yeast. Methods Enzymol (2002) 6.60
Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother (1996) 4.24
Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother (2000) 4.03
Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet (1995) 3.85
Candida albicans strains heterozygous and homozygous for mutations in mitogen-activated protein kinase signaling components have defects in hyphal development. Proc Natl Acad Sci U S A (1996) 3.65
Ras2 signals via the Cdc42/Ste20/mitogen-activated protein kinase module to induce filamentous growth in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1996) 3.61
Gametogenesis in yeast is regulated by a transcriptional cascade dependent on Ndt80. Mol Cell (1998) 3.58
Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob Agents Chemother (1998) 2.93
A recyclable Candida albicans URA3 cassette for PCR product-directed gene disruptions. Yeast (2000) 2.90
Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. J Clin Microbiol (2003) 2.70
Cassettes for PCR-mediated construction of green, yellow, and cyan fluorescent protein fusions in Candida albicans. Yeast (2001) 2.37
Mechanisms and clinical impact of antifungal drug resistance. J Med Vet Mycol (1994) 2.32
A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol Microbiol (2002) 2.14
Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. Antimicrob Agents Chemother (2001) 1.99
Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Antimicrob Agents Chemother (2004) 1.86
Mesoderm induction in Xenopus is a zygotic event regulated by maternal VegT via TGFbeta growth factors. Development (1999) 1.57
Identification of genes involved in epithelial-mesenchymal transition and tumor progression. Oncogene (2001) 1.45
Structure of the sporulation-specific transcription factor Ndt80 bound to DNA. EMBO J (2002) 1.31
Sequence comparison of yeast ATP-binding cassette proteins. Cold Spring Harb Symp Quant Biol (1995) 1.12
Biologic and clinical significance of HER-2/neu (cerbB-2) in breast cancer. Adv Anat Pathol (2000) 1.10
Crystal structure of the DNA-binding domain from Ndt80, a transcriptional activator required for meiosis in yeast. Proc Natl Acad Sci U S A (2002) 1.09
CDR1, a multidrug resistance gene from Candida albicans, contains multiple regulatory domains in its promoter and the distal AP-1 element mediates its induction by miconazole. FEMS Microbiol Lett (1999) 1.07
Mechanisms of antifungal agent resistance. J Microbiol Immunol Infect (2001) 1.04
Examining the relationship between cancer invasion/metastasis and drug resistance. Curr Cancer Drug Targets (2002) 0.90
[Antifungal susceptibility of yeasts by Etest. Comparison of 3 media]. Rev Med Chil (2003) 0.83
Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol (2007) 2.06
A simple scoring algorithm predicting vascular infections in adults with nontyphoid Salmonella bacteremia. Clin Infect Dis (2012) 1.75
Functional characterization of the microtubule-binding and -destabilizing domains of CPAP and d-SAS-4. Exp Cell Res (2008) 1.41
Species identification of medically important fungi by use of real-time LightCycler PCR. J Med Microbiol (2003) 1.26
Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Infect Control Hosp Epidemiol (2004) 1.22
Melioidosis outbreak after typhoon, southern Taiwan. Emerg Infect Dis (2007) 1.19
Assessment of Candida glabrata strain relatedness by pulsed-field gel electrophoresis and multilocus sequence typing. J Clin Microbiol (2007) 1.18
Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. Diagn Microbiol Infect Dis (2004) 1.18
Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species. J Clin Microbiol (2005) 1.15
Methicillin-resistant Staphylococcus aureus in Taiwan. Emerg Infect Dis (2005) 1.14
Multilocus sequence typing of Candida tropicalis shows clonal cluster enriched in isolates with resistance or trailing growth of fluconazole. Diagn Microbiol Infect Dis (2007) 1.12
Multilocus sequence typing for analyses of clonality of Candida albicans strains in Taiwan. J Clin Microbiol (2006) 1.11
Clinical significance and distribution of putative virulence markers of 116 consecutive clinical Aeromonas isolates in southern Taiwan. J Infect (2006) 1.10
Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species. BMC Infect Dis (2005) 1.09
The type 2 dengue virus envelope protein interacts with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9). J Biomed Sci (2007) 1.09
Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors. PLoS One (2007) 1.09
Molecular mechanisms of fluoroquinolone resistance. J Microbiol Immunol Infect (2003) 1.05
Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997-2010. PLoS One (2013) 1.04
Colonization of HIV-infected outpatients in Taiwan with methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Int J STD AIDS (2003) 1.03
Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan. J Microbiol Immunol Infect (2003) 1.03
Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002. Diagn Microbiol Infect Dis (2005) 1.01
Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006. Diagn Microbiol Infect Dis (2008) 0.96
Lack of catheter infection by the efg1/efg1 cph1/cph1 double-null mutant, a Candida albicans strain that is defective in filamentous growth. Antimicrob Agents Chemother (2002) 0.95
Effect of prolonged HAART on oral colonization with Candida and candidiasis. BMC Infect Dis (2006) 0.94
Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003. J Microbiol Immunol Infect (2006) 0.94
Easy strategy to increase salt resistance of antimicrobial peptides. Antimicrob Agents Chemother (2011) 0.93
Comparison of four molecular typing methods to assess genetic relatedness of Candida albicans clinical isolates in Taiwan. J Med Microbiol (2005) 0.91
Prognostic values of blood ammonia and partial pressure of ammonia on hospital arrival in out-of-hospital cardiac arrests. Am J Emerg Med (2012) 0.88
Fatal case of community-acquired bacteremia and necrotizing fasciitis caused by Chryseobacterium meningosepticum: case report and review of the literature. J Clin Microbiol (2006) 0.87
Increased potency of a novel D-beta-naphthylalanine-substituted antimicrobial peptide against fluconazole-resistant fungal pathogens. FEMS Yeast Res (2009) 0.86
Distribution and drug susceptibilities of Candida species causing candidemia from a medical center in central Taiwan. J Infect Chemother (2013) 0.86
In vitro activity of voriconazole against Candida species isolated in Taiwan. Int J Antimicrob Agents (2004) 0.85
Species distribution and antifungal susceptibility of blood Candida isolates at a tertiary hospital in southern Taiwan, 1999-2006. Mycoses (2009) 0.84
Two closely related fluconazole-resistant Candida tropicalis clones circulating in Taiwan from 1999 to 2006. Microb Drug Resist (2009) 0.84
Distribution and antifungal susceptibility of Candida species isolated from different age populations in Taiwan. Med Mycol (2006) 0.84
Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans. Fungal Genet Biol (2009) 0.83
Host factors do not influence the colonization or infection by fluconazole resistant Candida species in hospitalized patients. J Negat Results Biomed (2008) 0.83
Genotype analysis based on intergenic spacer 1 sequences of Trichosporon asahii collected in Taiwan. Med Mycol (2013) 0.83
Comparison of human and soil Candida tropicalis isolates with reduced susceptibility to fluconazole. PLoS One (2012) 0.82
The roles of mutations in gyrA, parC, and ompK35 in fluoroquinolone resistance in Klebsiella pneumoniae. Microb Drug Resist (2003) 0.82
Serum repressing efflux pump CDR1 in Candida albicans. BMC Mol Biol (2006) 0.82
The DNA-binding domain of CaNdt80p is required to activate CDR1 involved in drug resistance in Candida albicans. J Med Microbiol (2006) 0.82
Blocking the dengue virus 2 infections on BHK-21 cells with purified recombinant dengue virus 2 E protein expressed in Escherichia coli. Biochem Biophys Res Commun (2003) 0.81
Salvage therapy with tigecycline for recurrent infection caused by ertapenem-resistant extended-spectrum β-lactamase-producing Klebsiella pneumoniae. Diagn Microbiol Infect Dis (2010) 0.81
Molecular mechanisms of fluoroquinolone resistance in Klebsiella. Curr Drug Targets Infect Disord (2004) 0.81
Automatic method to compare the lanes in gel electrophoresis images. IEEE Trans Inf Technol Biomed (2007) 0.81
Aβ40(L17A/F19A) mutant diminishes the aggregation and neurotoxicity of Aβ40. Biochem Biophys Res Commun (2011) 0.80
A method of layer-by-layer gold nanoparticle hybridization in a quartz crystal microbalance DNA sensing system used to detect dengue virus. Nanotechnology (2009) 0.80
Association between fluconazole susceptibility and genetic relatedness among Candida tropicalis isolates in Taiwan. J Med Microbiol (2007) 0.80
Predisposing factors for oropharyngeal colonization of yeasts in human immunodeficiency virus-infected patients: a prospective cross-sectional study. J Microbiol Immunol Infect (2012) 0.79
Oropharyngeal colonization of HIV-infected outpatients in Taiwan by yeast pathogens. J Clin Microbiol (2010) 0.78
The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan. BMC Infect Dis (2005) 0.78
Decline of tetanus antitoxin level with age in taiwan. J Formos Med Assoc (2009) 0.78
Efg1 involved in drug resistance by regulating the expression of ERG3 in Candida albicans. Antimicrob Agents Chemother (2005) 0.78
Non-lethal Candida albicans cph1/cph1 efg1/efg1 mutant partially protects mice from systemic infections by lethal wild-type cells. Mycol Res (2008) 0.78
Aeromonas spontaneous bacterial peritonitis: a highly fatal infectious disease in patients with advanced liver cirrhosis. J Formos Med Assoc (2009) 0.77
Loss of heterozygosity of FCY2 leading to the development of flucytosine resistance in Candida tropicalis. Antimicrob Agents Chemother (2011) 0.77
Candida albicans ENO1 null mutants exhibit altered drug susceptibility, hyphal formation, and virulence. J Microbiol (2013) 0.76
Species distribution and drug susceptibilities of Candida isolates in TSARY 2010. Diagn Microbiol Infect Dis (2013) 0.76
Yeast oropharyngeal colonization in human immunodeficiency virus-infected patients in central taiwan. Mycopathologia (2014) 0.76
Macrolide combination antibiotic therapy should be prudently considered in complicated CAP cases and in regions with low macrolide susceptibility. Intensive Care Med (2010) 0.75
Resolution of galactomannan antigenemia in a patient receiving oral voriconazole for chronic necrotizing pulmonary aspergillosis. Diagn Microbiol Infect Dis (2011) 0.75
Characterization of Candida species from different populations in Taiwan. Mycopathologia (2011) 0.75
Positive tuberculin skin tests in nursing home residents in Southern Taiwan. Arch Gerontol Geriatr (2010) 0.75
Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole. J Microbiol Immunol Infect (2009) 0.75
Molecular epidemiology of emerging reduced susceptibility to fluoroquinolones in Escherichia coli. J Med Microbiol (2004) 0.75